Charged particles in radiotherapy: A 5-year update of a systematic review

Radiotherapy and Oncology

Volumn 103, Issue 1, 2012, Pages 5-7

  De Ruysscher, Dirk ^a   Mark Lodge, M ^b   Jones, Bleddyn ^c   Brada, Michael ^d   Munro, Alastair ^e   Jefferson, Thomas ^f   Pijls Johannesma, Madelon ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b INTERNATIONAL NETWORK FOR CANCER TREATMENT AND RESEARCH   (Belgium)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^e UNIVERSITY OF DUNDEE   (United Kingdom)

^f NONE

Author keywords

Charged particles; Proton therapy; Radiotherapy

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CLINICAL PRACTICE; CLINICAL RESEARCH; HUMAN; INTENSITY MODULATED RADIATION THERAPY; PRIORITY JOURNAL; PROCEDURES; PROTON THERAPY; RADIATION DOSE DISTRIBUTION; SYSTEMATIC REVIEW;

EID: 84859721819     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2012.01.003     Document Type: Review

References (42)

1. Suit H, DeLaney T, Goldberg S, et al. Proton vs carbon ion beams in the definitive radiation treatment of cancer patients. Radiother Oncol 2010;95: 3-22.
2. van de Water TA, Bijl HP, Schilstra C, et al. The potential benefit of radiotherapy with protons in head and neck cancer with respect to normal tissue sparing: a systematic review of literature. Oncologist 2011;16:366-77.
3. Combs SE, Jäkel O, Haberer T, Debus J. Particle therapy at the Heidelberg Ion Therapy Center (HIT) - integrated research-driven university-hospital-based radiation oncology service in Heidelberg, Germany. Radiother Oncol 2010;95: 41-4.
4. Ramaekers BL, Pijls-Johannesma M, Joore MA, et al. Systematic review and meta-analysis of radiotherapy in various head and neck: comparing photons, carbon-ions and protons. Cancer Treat Rev 2011;37:185-201.
5. Grutters JP, Kessels AG, Pijls-Johannesma M, et al. Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis. Radiother Oncol 2010;95:32-40.
6. Brada M, Pijls-Johannesma M, De Ruysscher D. Current clinical evidence for proton therapy. Cancer J 2009;15:319-24.
7. Olsen DR, Bruland OS, Frykholm G, et al. Proton therapy - a systematic review of clinical effectiveness. Radiother Oncol 2007;83:123-32. (Pubitemid 46776914)
8. Pijls-Johannesma M, Pommier P, Lievens Y. Cost-effectiveness of particle therapy: current evidence and future needs. Radiother Oncol 2008;89:127-34.
9. Pijls-Johannesma M, Grutters JP, Lambin P, et al. Particle therapy in lung cancer: where do we stand? Cancer Treat Rev 2008;34:259-67.
10. Lodge M, Pijls-Johannesma M, Stirk L, et al. A systematic literature review of the clinical and cost-effectiveness of hadron therapy in cancer. Radiother Oncol 2007;83:110-22. (Pubitemid 46776922)
11. Brada M, Pijls-Johannesma M, De Ruysscher D. Proton therapy in clinical practice: current clinical evidence. J Clin Oncol 2007;25:965-70. (Pubitemid 350002862)
12. Grutters JP, Pijls-Johannesma M, De Ruysscher D, et al. The cost-effectiveness of particle therapy in non-small cell lung cancer: exploring decision uncertainty and areas for future research. Cancer Treat Rev 2010;36:468-76.
13. Pijls-Johannesma M, Grutters JP, Verhaegen F, et al. Do we have enough evidence to implement particle therapy as standard treatment in lung cancer? A systematic literature review. Oncologist 2010;15:93-103.
14. Konski A, Speier W, Hanlon A, et al. Is proton beam therapy cost effective in the treatment of adenocarcinoma of the prostate? J Clin Oncol 2007;25:3603-8. (Pubitemid 47372597)
15. Lundkvist J, Ekman M, Ericsson SR, et al. Economic evaluation of proton radiation therapy in the treatment of breast cancer. Radiother Oncol 2005;75: 179-85. (Pubitemid 40805247)
16. Jäkel O, Land B, Combs SE, et al. On the cost-effectiveness of carbon ion radiation therapy for skull base chordoma. Radiother Oncol 2007;83:133-8. (Pubitemid 46776917)
17. Paganetti H, Niemierko A, Ancukiewicz M, et al. Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys 2002;53:407-21. (Pubitemid 34522107)
18. Suit H, Kooy H, Trofimov A, et al. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No Radiother Oncol 2008;86:148-53.
19. Goitein M, Cox JD. Should randomized clinical trials be required for proton radiotherapy? J Clin Oncol 2008;26:175-6.
20. Bentzen SM. Randomized controlled trials in health technology assessment: overkill or overdue? Radiother Oncol 2008;86:142-7.
21. Glimelius B, Montelius A. Proton beam therapy - do we need the randomised trials and can we do them? Radiother Oncol 2007;83:105-9. (Pubitemid 46776924)
22. Tepper JE. Protons and parachutes. J Clin Oncol 2008;26:2436-7.
23. Glatstein E, Glick J, Kaiser L, et al. Should randomized clinical trials be required for proton radiotherapy? An alternative view. J Clin Oncol 2008;26:2438-9.
24. Martin S, Chen JZ, Rashid Dar A, et al. Dosimetric comparison of helical tomotherapy, RapidArc, and a novel IMRT & Arc technique for esophageal carcinoma. Radiother Oncol 2011;101:431-7.
25. Chan OS, Lee MC, Hung AW, et al. The superiority of hybrid-volumetric arc therapy (VMAT) technique over double arcs VMAT and 3D-conformal technique in the treatment of locally advanced non-small cell lung cancer -a planning study. Radiother Oncol 2011;101:298-302.
26. Fogliata A, Bergström S, Cafaro I, et al. Cranio-spinal irradiation with volumetric modulated arc therapy: a multi-institutional treatment experience. Radiother Oncol 2011;99:79-85.
27. Ong CL, Verbakel WF, Cuijpers JP, et al. Stereotactic radiotherapy for peripheral lung tumors: a comparison of volumetric modulated arc therapy with 3 other delivery techniques. Radiother Oncol 2010;97:437-42.
28. Roelofs E, Engelsman M, Rasch C, et al. Results of a multicentric in silico clinical trial (ROCOCO): comparing radiotherapy with photons and protons for non-small cell lung cancer. J Thorac Oncol 2012;7:165-76.
29. Advisory Group on Ionising Radiation. Circulatory disease risk. Health Protection Agency, UK [ISBN: 978-0-85951-676-1].
30. Kim S, Min BJ, Yoon M, et al. Secondary radiation doses of intensity-modulated radiotherapy and proton beam therapy in patients with lung and liver cancer. Radiother Oncol 2011;98:335-9.
31. Athar BS, Paganetti H. Comparison of second cancer risk due to out-of-field doses from 6-MV IMRT and proton therapy based on 6 pediatric patient treatment plans. Radiother Oncol 2011;98:87-92.
32. Simone 2nd CB, Ly D, Dan TD, et al. Comparison of intensity-modulated radiotherapy, adaptive radiotherapy, proton radiotherapy, and adaptive proton radiotherapy for treatment of locally advanced head and neck cancer. Radiother Oncol 2011;101:376-82.
33. Schwarz M, Pierelli A, Fiorino C, et al. Helical tomotherapy and intensity modulated proton therapy in the treatment of early stage prostate cancer: a treatment planning comparison. Radiother Oncol 2011;98:74-80.
34. Wolff HA, Wagner DM, Conradi LC, et al. Irradiation with protons for the individualized treatment of patients with locally advanced rectal cancer: a planning study with clinical implications. Radiother Oncol 2012;102:30-7.
35. Toscas JI, Linero D, Rubio I, et al. Boosting the tumor bed from deep-seated tumors in early-stage breast cancer: a planning study between electron, photon, and proton beams. Radiother Oncol 2010;96:192-8.
36. Goitein M. Trials and tribulations in charged particle radiotherapy. Radiother Oncol 2010;95:23-31.
37. Zietman A, Goitein M, Tepper JE. Technology evolution: is it survival of the fittest? J Clin Oncol 2010;28:4275-9.
38. Knopf A, Bert C, Heath E, et al. Special report: workshop on 4D-treatment planning in actively scanned particle therapy - recommendations, technical challenges, and future research directions. Med Phys 2010;37:4608-14.
39. Knopf AC, Hong TS, Lomax A. Scanned proton radiotherapy for mobile targets -the effectiveness of re-scanning in the context of different treatment planning approaches and for different motion characteristics. Phys Med Biol 2011;56:7257-71.
40. Seco J, Robertson D, Trofimov A, et al. Breathing interplay effects during proton beam scanning: simulation and statistical analysis. Phys Med Biol 2009;54:N283-94.
41. Grutters JP, Abrams KR, de Ruysscher D, et al. When wait for more evidence? Real options analysis in proton therapy. Oncologist 2011;16:1752-61.
42. Peeters A, Grutters JP, Pijls-Johannesma M, et al. How costly is particle therapy? Cost analysis of external beam radiotherapy with carbon-ions, protons and photons. Radiother Oncol 2010;95:45-53.